[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@bronxb_13 Bronx KidBronx Kid posts on X about $srpt, if you, seed funding, business the most. They currently have XX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence finance XXXXX% stocks XXXXX%
Social topic influence $srpt 14.29%, if you 7.14%, seed funding 7.14%, business 7.14%, $dyn 7.14%, just a 7.14%, $capr XXXX%
Top accounts mentioned or mentioned by @jacqueskahn @rnaianalyst @heikwantrades @zm2514 @markland55 @augurbio @jlucer53 @avidresearch @pinkerste94119 @fidelisaurelius @jonnyfunguy @pickingmyown @therealj_money
Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Dyne Therapeutics, Inc. Common Stock (DYN)
Top posts by engagements in the last XX hours
"@HeikwanTrades U r missing the point. Has nothing to do with the companies mentioned in the letter. Why would anyone invest in ANY early stage biotech if you cant trust the guidance the FDA is giving out This flip flopping has driven investors out of the sector and killed seed funding"
X Link 2025-11-22T02:58Z XX followers, 5331 engagements
"@HeikwanTrades Have you spoken to any pre-seed/early stage biotech company personnel Very little investing in early stage rare disease at the moment from who I speak to"
X Link 2025-11-22T03:13Z XX followers, XXX engagements
"@markland_55 @RNAiAnalyst $SRPT whole business was based on AA too early those days are completely over and $DYN doesnt offer anything novel just a slightly improved drug. Run a RCT and come back in a few years"
X Link 2025-12-08T14:18Z XX followers, XXX engagements
"@FidelisAurelius @Jonny_fun_guy @PickingMyOwn Agreed. $CAPR complementary (especially for older boys). This would be final nail in coffin for $SRPT on the other hand"
X Link 2025-12-11T01:30Z XX followers, XXX engagements